AAAAAA

   
Results: 1-8 |
Results: 8
HEMODYNAMIC PROFILE IN SEVERE ARDS - RESULTS OF THE EUROPEAN COLLABORATIVE ARDS STUDY
Authors: SQUARA P DHAINAUT JFA ARTIGAS A CARLET J
Citation: P. Squara et al., HEMODYNAMIC PROFILE IN SEVERE ARDS - RESULTS OF THE EUROPEAN COLLABORATIVE ARDS STUDY, Intensive care medicine, 24(10), 1998, pp. 1018-1028
CONFIRMATORY INTERLEUKIN-1 RECEPTOR ANTAGONIST TRIAL IN SEVERE SEPSIS- A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL
Authors: OPAL SM FISHER CJ DHAINAUT JFA VINCENT JL BRASE R LOWRY SF SADOFF JC SLOTMAN GJ LEVY H BALK RA SHELLY MP PRIBBLE JP LABRECQUE JF LOOKABAUGH J DONOVAN H DUBIN H BAUGHMAN R NORMAN J DEMARIA E MATZEL K ABRAHAM E SENEFF M BARBER A BRAYMAN K CERRA F CHALFIN D CHAZEN G CHRISTOU N COONEY R CORBIN R DREW R EMMANUEL G PINES B ERON L FLETCHER R FOULKE G GALLAGHER T GERVICH D GROSSMAN J HALPERN N HANNA C JOHNSON S KUBAK B LODATO R LOVETT M MARSHALL J METZLER M NELSON L FREELAND M OROPELLO J PAZ H RACKOW E RIKER R RISSING P SCHEIN R SCHELD M SCHUSTER D SIBBALD W SILVERMAN H SOMERMEYER M STRANGE C SUMMER W TOPIEL M WHITE J ALESTIG K ANDERSEN PK ANDERSSON J BENNETT D BERG S BLEICHNER G BRUNET F CARLET J DEJONG MJ DREXLER H GARRARD C HESLET L KLOSS T PAUL W REINHART K RENAUD B RITZ R ROMME JH SCHMITZ JE STOCKENHUBER F SUTER P TENAILLON A VAGT A VANDERMEER WM VANDEVENTER S VANLEEUWEN PAM VERHOEF J WEBSTER N WINTER RJ WOLFF M STILES DM DEVOS A CROFT C FAZIO J THOMPSON R WIEDEMANN H ELLISON RT CHINCHILLI VM YARBOROUGH M
Citation: Sm. Opal et al., CONFIRMATORY INTERLEUKIN-1 RECEPTOR ANTAGONIST TRIAL IN SEVERE SEPSIS- A PHASE-III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER TRIAL, Critical care medicine, 25(7), 1997, pp. 1115-1124
IMMEDIATE CORONARY ANGIOGRAPHY IN SURVIVORS OF OUT-OF-HOSPITAL CARDIAC-ARREST
Authors: SPAULDING CM JOLY LM ROSENBERG A MONCHI M WEBER SN DHAINAUT JFA CARLI P
Citation: Cm. Spaulding et al., IMMEDIATE CORONARY ANGIOGRAPHY IN SURVIVORS OF OUT-OF-HOSPITAL CARDIAC-ARREST, The New England journal of medicine, 336(23), 1997, pp. 1629-1633
CDP571, A HUMANIZED ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA - SAFETY, PHARMACOKINETICS, IMMUNE-RESPONSE, AND INFLUENCE OF THE ANTIBODY ON CYTOKINE CONCENTRATIONS IN PATIENTS WITH SEPTIC SHOCK
Authors: DHAINAUT JFA VINCENT JL RICHARD C LEJEUNE P MARTIN C FIEROBE L STEPHENS S NEY UM SOPWITH M MERCAT A EDOUARD A FRIEDMAN G MARIN N SCHLEMMER B LEPAPE A NOVAK C
Citation: Jfa. Dhainaut et al., CDP571, A HUMANIZED ANTIBODY TO HUMAN TUMOR-NECROSIS-FACTOR-ALPHA - SAFETY, PHARMACOKINETICS, IMMUNE-RESPONSE, AND INFLUENCE OF THE ANTIBODY ON CYTOKINE CONCENTRATIONS IN PATIENTS WITH SEPTIC SHOCK, Critical care medicine, 23(9), 1995, pp. 1461-1469
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME (VOL 271, PG 1836, 1994)
Authors: FISHER CJ DHAINAUT JFA OPAL SM PRIBBLE JP BALK RA SLOTMAN GJ IBERTI TJ RACKOW EC SHAPIRO MJ GREENMAN RL REINES HD SHELLY MP THOMPSON BW LABRECQUE JF CATALANO MA KNAUS WA SADOFF JC
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME (VOL 271, PG 1836, 1994), JAMA, the journal of the American Medical Association, 272(15), 1994, pp. 1170-1170
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: FISHER CJ DHAINAUT JFA OPAL SM PRIBBLE JP BALK RA SLOTMAN GJ IBERTI TJ RACKOW EC SHAPIRO MJ GREENMAN RL REINES HD SHELLY MP THOMPSON BW LABRECQUE JF CATALANO MA KNAUS WA SADOFF JC ASTIZ M CARPATI C BONE RC FREIDMAN B MURE AJ BRATHWAITE C SHAPIRO E MELHORN L TAYLOR R KEEGAN M OBRIEN J SCHEIN R PENA M WASSERLOUF M OROPELLO J BENJAMIN E DELGUIDICE R EMMANUEL G LIE T ANDERSON L MARSHALL J DEMAJO W ROTSTEIN O FOSTER D ABRAHAM E MIDDLETON H PERRY C LEVY H FRY DE SIMPSON SQ CROWELL RE NEIDHART M STEVENS D COFFMAN T NARASIMHAM N MERRICK DK BERGQUIST W MATZEL KE HUEBLER M FOULKE GE ALBERTSON TE WALBY WF ALLEN RP BAUGHMAN R HASSELGREN PO FINK MP FAVORITO F THOMPSON BT CORBIN R SHELLHORSE GY FRAZIER A WHITE S GARRARD C ACOURT C STORER S GERVICH DH FOSHE D BRASE R BAGDAHN A COONEY R SMITH JS MARTIN LF VINCENT JL FRIEDMAN G BERLOT G FLETCHER JR WILLIAMS MD WRIGHT TF JOHNSON S FEILD C WOLF K MACINTYRE N DUBIN HG DURKIN MR DUBIN PK STAUBACH KH FEIN AM SCHULMAN DB NIEDERMAN MS CHALFIN DB VANLEEUWEN PAM BOERMEESTER MA SCHNEIDER AJ BANDER J IMM A BERNARD G NELSON L STROUD M SAFCSAK K CERRA F RINDAL J MANN H HALPERN N SILVERSTEIN J ALICEA M SIBBALD WJ MARTIN CM RUTLEDGE FS PETTI K RUSSELL JA KRUGER R DRUMMOND A LANGE P SEIFERT T DUROCHER A TENAILLON A BOITEAU R LHERM T LOWRY SF COYLE SM BARIE PS DEMARIA E SNYDMAN DR SCHWAITZBERG SD NASRAWAY SA GRINDLINGER J SUMMER W DEBOISBLANC B WAHL M ALESTIG K GROSSMAN J MAKI D PAZ HL WEINER M BIHARI D CAMPBELL D BLEICHNER G DAHN MS LANGE MPA HALL J POHLMAN A WENZEL RP GROSSERODE M COSTIGAN M MILESKI W WEIGELT J YESTON N IRIZARRY C ROSS J ROBBINS J NIGHTINGALE P OWEN K SANDSTEDT S BERG S SIMON GL SENEFF MG CONRY KM ZIMMERMAN JL DELLINGER RP JOHNSTON R ALLEE P GRANDE PO MYHRE E DHAINAUT JF HAMY I MIRA JP HARMON J WHITE J MCKIE L SILVERMAN H TUMA P BENNETT D PORTER JC LAURELL MH JACOBS S ASH S STILES DM PRIOR MJ KNATTERUD G TERRIN M KUFERA J WILKENS P RA K MONROE L SPRUNG C HAMILTON CM MATTHAY R MCCABE W TONASCIA J WIEDEMAN H WITTES J CAMPION GV CROFT CR LUSTICK R LOOKABAUGH J GORDON GS NOE L BLOEDOW D SMITH CG BRANNON D KUSH R NG D MOORE E BAZEMORE K GALVAN M WAGNER D HARRELL F STABLEIN D
Citation: Cj. Fisher et al., RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF PATIENTS WITH SEPSIS SYNDROME - RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, JAMA, the journal of the American Medical Association, 271(23), 1994, pp. 1836-1843
PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER CLINICAL-TRIAL
Authors: DHAINAUT JFA TENAILLON A LETULZO Y SCHLEMMER B SOLET JP WOLFF M HOLZAPFEL L ZENI F DREYFUSS D MIRA JP DEVATHAIRE F GUINOT P
Citation: Jfa. Dhainaut et al., PLATELET-ACTIVATING-FACTOR RECEPTOR ANTAGONIST BN-52021 IN THE TREATMENT OF SEVERE SEPSIS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER CLINICAL-TRIAL, Critical care medicine, 22(11), 1994, pp. 1720-1728
LACK OF OXYGEN-SUPPLY DEPENDENCY IN PATIENTS WITH SEVERE SEPSIS - A STUDY OF OXYGEN DELIVERY INCREASED BY MILITARY ANTISHOCK TROUSER AND DOBUTAMINE
Authors: MIRA JP FABRE JE BAIGORRI F COSTE J ANNAT G ARTIGAS A NITENBERG G DHAINAUT JFA
Citation: Jp. Mira et al., LACK OF OXYGEN-SUPPLY DEPENDENCY IN PATIENTS WITH SEVERE SEPSIS - A STUDY OF OXYGEN DELIVERY INCREASED BY MILITARY ANTISHOCK TROUSER AND DOBUTAMINE, Chest, 106(5), 1994, pp. 1524-1531
Risultati: 1-8 |